Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00257127 · ClinicalTrials.gov registry record · NA

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

A NA study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
NA
Development phase
101
Enrollment target
20
Study locations

NCT00257127: Completed NA study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00257127 is a NA study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 101 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00257127, a NA study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine immune system function following vaccination in HIV-infected children currently taking anti-HIV drugs. To test the effectiveness of prior vaccination, patients in this study will receive booster shots of one of two pneumococcal vaccines, a hepatitis B vaccine, and a measles vaccine.

Conditions Studied

HIV Infections

Interventions

  • BIOLOGICAL Pneumococcal 7-valent conjugate vaccine
  • BIOLOGICAL Pneumococcal polysaccharide vaccine
  • BIOLOGICAL Hepatitis B vaccine
  • BIOLOGICAL Measles, mumps, and rubella virus vaccine, live

Study Locations (20)

New York

  • SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS - Brooklyn
  • Nyu Ny Nichd Crs - New York
  • Metropolitan Hosp. Ctr. - New York
  • Harlem Hosp. Ctr. NY NICHD CRS - New York

California

  • Usc La Nichd Crs - Alhambra
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. - Long Beach
  • UCSD Mother-Child-Adolescent Program CRS - San Diego

Florida

  • South Florida CDTC Ft Lauderdale NICHD CRS - Fort Lauderdale
  • Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy - Gainesville
  • Univ. of Florida Jacksonville NICHD CRS - Jacksonville

Massachusetts

  • HMS - Children's Hosp. Boston, Div. of Infectious Diseases - Boston
  • BMC, Div. of Ped Infectious Diseases - Boston
  • WNE Maternal Pediatric Adolescent AIDS CRS - Worcester

Illinois

  • Chicago Children's CRS - Chicago
  • Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease - Chicago

Alabama

  • UAB, Dept. of Ped., Div. of Infectious Diseases - Birmingham

Colorado

  • Univ. of Colorado Denver NICHD CRS - Aurora

Connecticut

  • Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease - New Haven

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2006-02
Est. Completion 2006-08
Phase NA
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00257127 record still lists

NCT00257127 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (77% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Pneumococcal 7-valent conjugate vaccine is the first listed.

NCT00257127 names 20 study sites across 10 states, led by New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00257127 about?

NCT00257127 is a clinical study titled "Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs". The purpose of this study is to determine immune system function following vaccination in HIV-infected children currently taking anti-HIV drugs. To test the effectiveness of prior vaccination, patients in this study will receive booster shots of one of two pneumococcal vaccines, a hepatitis B vaccin...

What is the current status of trial NCT00257127?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2006-02. Estimated completion is 2006-08.

What conditions does trial NCT00257127 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00257127?

The interventions under investigation include: Pneumococcal 7-valent conjugate vaccine (BIOLOGICAL), Pneumococcal polysaccharide vaccine (BIOLOGICAL), Hepatitis B vaccine (BIOLOGICAL), Measles, mumps, and rubella virus vaccine, live (BIOLOGICAL).

Who is sponsoring clinical trial NCT00257127?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00257127 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00257127's enrollment target sits among peer trials

101 265th of 542 higher than 277 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00257127, the US trial registry maintained by the National Library of Medicine. NCT00257127 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.